1. Home
  2. DVA vs AYI Comparison

DVA vs AYI Comparison

Compare DVA & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • AYI
  • Stock Information
  • Founded
  • DVA 1994
  • AYI 2001
  • Country
  • DVA United States
  • AYI United States
  • Employees
  • DVA N/A
  • AYI N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • AYI Building Products
  • Sector
  • DVA Health Care
  • AYI Consumer Discretionary
  • Exchange
  • DVA Nasdaq
  • AYI Nasdaq
  • Market Cap
  • DVA 9.4B
  • AYI 10.8B
  • IPO Year
  • DVA 1995
  • AYI N/A
  • Fundamental
  • Price
  • DVA $126.99
  • AYI $364.00
  • Analyst Decision
  • DVA Hold
  • AYI Buy
  • Analyst Count
  • DVA 3
  • AYI 6
  • Target Price
  • DVA $151.00
  • AYI $395.17
  • AVG Volume (30 Days)
  • DVA 634.2K
  • AYI 353.3K
  • Earning Date
  • DVA 10-29-2025
  • AYI 10-01-2025
  • Dividend Yield
  • DVA N/A
  • AYI 0.19%
  • EPS Growth
  • DVA 8.72
  • AYI N/A
  • EPS
  • DVA 10.20
  • AYI 12.53
  • Revenue
  • DVA $13,161,328,000.00
  • AYI $4,345,600,000.00
  • Revenue This Year
  • DVA $5.96
  • AYI $10.80
  • Revenue Next Year
  • DVA $3.54
  • AYI $5.15
  • P/E Ratio
  • DVA $12.35
  • AYI $28.46
  • Revenue Growth
  • DVA 5.09
  • AYI 13.14
  • 52 Week Low
  • DVA $122.93
  • AYI $216.81
  • 52 Week High
  • DVA $179.60
  • AYI $375.67
  • Technical
  • Relative Strength Index (RSI)
  • DVA 43.89
  • AYI 59.06
  • Support Level
  • DVA $124.60
  • AYI $347.19
  • Resistance Level
  • DVA $127.92
  • AYI $372.64
  • Average True Range (ATR)
  • DVA 2.70
  • AYI 12.43
  • MACD
  • DVA -0.05
  • AYI -0.21
  • Stochastic Oscillator
  • DVA 33.90
  • AYI 59.88

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About AYI Acuity Brands Inc.

Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.

Share on Social Networks: